Effect of intravitreal bevacizumab injection before ahmed glaucoma valve implantation in neovascular glaucoma

Ophthalmologica

Volumn 229, Issue 2, 2013, Pages 94-100

  Sevim, Mehmet Sahin ^a   Buttanri, Ibrahim Bulent ^a   Kugu, Suleyman ^b   Serin, Didem ^a   Sevim, Semra ^c  

^a Department of Surgery   (Turkey)

^b Kartal Lutfi Kirdar Research and Education Hospital   (Turkey)

^c Uskudar State Hospital   (Turkey)

Author keywords

Ahmed glaucoma valve; Intravitreal bevacizumab; Neovascular glaucoma

Indexed keywords

BEVACIZUMAB; MITOMYCIN;

ADULT; AGED; ANTERIOR EYE CHAMBER DISEASE; APHAKIA; AQUEOUS HUMOR; ARTICLE; CASE STUDY; CENTRAL RETINA VEIN OCCLUSION; CILIARY BODY; CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA EDEMA; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLAUCOMA DRAINAGE IMPLANT; HUMAN; HYPHEMA; INJECTION; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MALE; MEDICAL RECORD REVIEW; NEOVASCULAR GLAUCOMA; OCULAR ISCHEMIC SYNDROME; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PSEUDOPHAKIA; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SLIT LAMP; TRABECULECTOMY; VITRECTOMY; AHMED GLAUCOMA VALVE; ANTERIOR EYE CHAMBER; COMPARATIVE STUDY; IMPLANT; IMPLANTATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TONOMETRY, OCULAR; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84873322492     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000345490     Document Type: Article

References (31)

1. Casey R, Li WW: Factors controlling ocular angiogenesis. Am J Ophthalmol 1997; 124: 521-529. (Pubitemid 27425876)
2. Sivack-Callcott JA, O'Day DM, Gass JD, Tsai JC: Evidence based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001; 108: 1767-1776. (Pubitemid 32905930)
3. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP: Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998; 105: 232-237. (Pubitemid 28090825)
4. Duker JS, Brown GC: The efficacy of panretinal photocoagulation for neovascularization of the iris after central retinal artery obstruction. Ophthalmology 1989; 96: 92-95. (Pubitemid 19041334)
5. Ehler JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W: Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina 2008; 28: 696-702. (Pubitemid 351655121)
6. Sisto D, Vetrugno M, Trabucco T, Cantatore F, Ruggeri G, Sborgia C: The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up. Acta Ophthalmol Scand 2007; 85: 267-271. (Pubitemid 46711363)
7. Kiuchi Y, Sugimoto R, Nakae K, Saito Y, Uto S: Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. Ophthalmologica 2006; 220: 383-388. (Pubitemid 44725975)
8. Tsai JC, Feuer WJ, Parrish RK II, Grajewski AL: 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of original pilot study. Ophthalmology 1995; 102: 887-892.
9. Hong CH, Arosemena A, Zurakowski D, Ayyala RS: Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol 2005; 50: 48-60. (Pubitemid 40038562)
10. Silva Paula J, Jorge R, Alves Costa R, Rodriques M de L, Scott IU: Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand 2006; 84: 556-557. (Pubitemid 44102857)
11. Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM: Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006; 142: 1054-1056. (Pubitemid 44853889)
12. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342. (Pubitemid 38702844)
13. Kahook MY, Schuman JS, Noecker RJ: Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Laser Imaging 2006; 37: 144-146.
14. Fakhraie G, Katz LJ, Prasad A, Eslami Y, Sabour S, Zarei R, Moghimi S: Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma. J Glaucoma 2010; 19: 212-218.
15. Miki A, Oshima Y, Otori Y, Kamei M, Tano Y: Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma. Br J Ophthalmol 2008; 92: 1431-1433.
16. Pokroy R, Greenwald Y, Pollack A, Bukelman A, Zalish M: Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2008; 39: 22-29. (Pubitemid 351311093)
17. Iliev ME, Gerber S: Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2007; 91: 1631-1635. (Pubitemid 350207389)
18. Mermoud A, Salmon JE, Alexander P, Straker C, Murray AD: Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome. Ophthalmology 1993; 100: 897-902. (Pubitemid 23163501)
19. Sidoti PA, Dunphy TR, Baerveldt G, LaBree L, Minckler DS, Lee PP, Heuer DK: Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology 1995; 102: 1107-1118.
20. Park UC, Park KH, Kim DM, Yu HG: Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy. J Glaucoma 2011; 20: 433-438.
21. Patel S, Pasquale LR: Glaucoma drainage devices: a review of the past, present, and future. Semin Ophthalmol 2010; 25: 265-270.
22. Jonas JB, Golubkina L, Libondi T, Rensch F: Intravitreal bevacizumab for neovascular glaucoma. Acta Ophthalmol 2010; 88:e22-e23.
23. Ma KT, Yang JY, Kim NR, Hong S, Lee ES, Seong GJ, Kim CY: Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma. J Glaucoma 2012; 21: 331-336.
24. Yalvac IS, Eksioglu U, Satana B, Duman S: Long-term results of Ahmed valve and Molteno implant in neovascular glaucoma. Eye 2007; 21: 65-70. (Pubitemid 46061872)
25. Every SG, Molteno AC, Bevin TH, Herbison P: Long-term results of Molteno implant insertion in cases of neovascular glaucoma. Arch Ophthalmol 2006; 124: 355-360.
26. Ayyala RS, Layden WE, Slonim CB, Margo CE: Anatomic and histopathologic findings following a failed Ahmed glaucoma valve device. Ophthalmic Surg Lasers 2001; 32: 248-249.
27. Lama PJ, Fechtner RD: Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003,48: 314-346. (Pubitemid 36549254)
28. YuXB, Sun XH, Dahan E, Gou WY, Qian SH, Meng FR, Song YL, Simon GJ: Increased levels of transforming growth factor-beta 1 and 2 in the aqueous humor of patients with neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2007,38: 6-14. (Pubitemid 46207322)
29. Kim YG, Hong S, Lee CS, Kang SY, Seong GJ, Ma KT, Kim CY: Level of vascular endothelial growth factor in aqueous humor and surgical results of Ahmed glaucoma valve implantation in patients with neovascular glaucoma. J Glaucoma 2009,18: 443-447.
30. Grewal DS, Jain R, Kumar H, Grewal SP: Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy. Ophthalmology 2008; 115: 2141-2145.
31. Nissen N, Polverini PJ, Koch AE: Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998; 152: 1445-1452. (Pubitemid 28275003)